Awaiting FDA Reclassification

CJC-1295 Therapy

Growth Hormone Optimization

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone naturally. It's often used in combination with Ipamorelin for synergistic effects.

Pending FDA Reclassification

CJC-1295 is currently classified as a Category 2 peptide by the FDA, meaning it cannot yet be compounded by US pharmacies for patient use. In February 2026, HHS signaled intent to reclassify up to 14 peptides back to Category 1 — which would allow licensed compounding pharmacies to prepare them under physician prescription. We are closely monitoring this process.

Be First in Line for CJC-1295

Join the waitlist and we'll notify you the moment physician-guided CJC-1295 therapy becomes available through Zelvimed.

No spam. Unsubscribe anytime. We'll only email you when CJC-1295 becomes available.

You're on the list! We'll notify you as soon as CJC-1295 is available.

Why CJC-1295?

What the research says about CJC-1295 (with or without DAC)

N

Natural GH Stimulation

CJC-1295 promotes the body's own growth hormone production rather than introducing exogenous GH, maintaining natural pulsatile release patterns.

I

Improved Body Composition

Higher growth hormone levels support fat metabolism and lean muscle development, helping improve overall body composition over time.

E

Enhanced Recovery & Sleep

Growth hormone peaks during deep sleep — CJC-1295 may enhance sleep quality and accelerate recovery from exercise and injury.

A

Anti-Aging Benefits

Optimized growth hormone levels are associated with improved skin elasticity, energy levels, cognitive function, and overall vitality.

Who is CJC-1295 For?

Adults experiencing age-related growth hormone decline, athletes seeking recovery optimization, and individuals interested in body composition and anti-aging.

Don't Miss the Window

When CJC-1295 becomes available, demand will be high. Get on the waitlist now to secure early access to physician-guided therapy through Zelvimed.

Join 0 others waiting for CJC-1295 access.

You're on the list! We'll notify you as soon as CJC-1295 is available.